Evidence map›Paper›PMID 39853333›Full record

ArticleEuropean radiology2025

The prognostic value of baseline EARL standardized FDG PET indices in pediatric and adolescent high-grade osteosarcoma.

Roelof van Ewijk, Rana Dandis, Janna Rodewijk, Bart de Keizer, Simone A J Ter Horst, Michiel A J van de Sande, Lizz van der Heijden, Johannes H M Merks, Lianne M Haveman, Arthur J A T Braat

Abstract read
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roelof van EwijkPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. r.vanewijk-2@prinsesmaximacentrum.nl.ORCID http://orcid.org/0000-0003-0339-6031
Rana DandisPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Janna RodewijkPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Bart de KeizerPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Simone A J Ter HorstPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Michiel A J van de SandePrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Lizz van der HeijdenPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Johannes H M MerksPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Lianne M Haveman *Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Arthur J A T Braat *Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the prognostic value of baseline European Association of Nuclear Medicine Research Ltd. (EARL) standardized [ MATERIALS AND

methodsPediatric and adolescent patients with high-grade osteosarcoma were included. Baseline [

resultsIn total, 66 patients were included in this study. In the univariable Cox regression analysis, peak lean-body mass corrected SUV (SUL

conclusionIn this study, the baseline EARL-standardized [ KEY POINTS: Question Prognostic value of baseline [

Indexed as

Bone NeoplasmsFluorodeoxyglucose F18OsteosarcomaPositron Emission Tomography Computed TomographyAdolescentChildFemaleHumansMaleNeoplasm GradingPrognosisRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18RadiopharmaceuticalsOsteosarcomaPediatricsPET-CTPrognostic factorsQuality control.

Identifiers

PMID39853333
PMCPMC12166021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.